Business
Why Alterity Therapeutics (ASX:ATH) share price has surged up 27% today // Motley Fool Australia
The Alterity Therapeutics Ltd (ASX: ATH) share price has rocketed up 27% this morning after its patent was approved by the United States Patent and Trademark Office. At the time of writing, the Alterity share price is trading up at 3.3 cents.
Approval of US patent
The new patent is the result of Alterity’s in-house discovery research and is central to its next generation drug development portfolio focused on neurodegenerative diseases.
Alterity’s lead product, ATH434, is showing potential to treat various forms of atypical Parkinsonism. Parkinsonian disorders are a group of diseases in which individuals experience slowness of movement, stiffness and tremor. They include Parkinson’s disease and Multiple System Atrophy, as…
-
Business24 hours agoThese ASX 200 shares could rise 50% to 60%
-
General23 hours agoAustralia’s Myanmar community mourns earthquake losses
-
General22 hours agoPeter Dutton partially walks back public service work-from-home vow
-
Noosa News20 hours agoDisaster relief packages announced for flood-stricken western Queensland